Agnes Mullady, Director at Gabelli Healthcare & WellnessRx Trust (GRX), bought 150 shares at $12.75 ($2K) on 2022-02-17, disclosed to the SEC on 2022-02-18.
Open-market purchase of $2k GRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| GCV | BUY | 2022-02-18 | $912 | — | Filing → |
| GDL | BUY | 2022-02-18 | $1K | — | Filing → |
| BCV | BUY | 2022-02-18 | $3K | — | Filing → |